Insider · CIK 0001397636

Denoyer Bernard

Reports to the SEC for 4 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001397636

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-08	OKYOOKYO Pharma Ltd · OptionA Award	Director	AAward	+3,500 sh	$1.85	+$6,475	35,190
2016-06-24	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+150K sh	—	—	991,017
2015-09-29	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+100K sh	—	—	841,017
2015-09-14	SYNERGY PHARMACEUTICALS LLCM Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	+10K sh	$3.40	+$34K	10,000
2015-09-14	SYNERGY PHARMACEUTICALS LLCS Sale	Senior Vice President, Finance	SSale	−10K sh	$7.50	−$75K	0
2015-09-14	SYNERGY PHARMACEUTICALS LLCStock OptionsM Exercise/Conversion	Senior Vice President, Finance	MExercise/Conversion	−10K sh	—	—	741,017
2015-07-24	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+75K sh	—	—	751,017
2014-12-06	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+156K sh	—	—	676,017
2014-02-18	HEPAHepion Pharmaceuticals, Inc.J Other	Chief Financial Officer	JOther	+1,030 sh	—	—	1,030
2014-01-24	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+10K sh	—	—	20,000
2013-11-26	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+10K sh	—	—	10,000
2013-07-12	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+75K sh	—	—	445,017
2013-07-12	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+75K sh	—	—	503,486
2013-06-21	SYNERGY PHARMACEUTICALS LLCP Purchase	Senior Vice President, Finance	PPurchase	+7,500 sh	$4.78	+$35.9K	7,500
2013-01-17	CALLISTO PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−100K sh	—	—	0
2013-01-17	CALLISTO PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−75K sh	—	—	0
2013-01-17	CALLISTO PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−75K sh	—	—	0
2013-01-17	CALLISTO PHARMACEUTICALS INCStock OptionsD Disposition to Issuer	Senior Vice President, Finance	DDisposition to Issuer	−75K sh	—	—	0
2013-01-17	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+18K sh	—	—	388,007
2013-01-17	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+13.5K sh	—	—	401,500
2013-01-17	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+13.5K sh	—	—	414,993
2013-01-17	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+13.5K sh	—	—	428,486
2013-01-17	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+18K sh	—	—	388,007
2013-01-17	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+13.5K sh	—	—	401,500
2013-01-17	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+13.5K sh	—	—	428,486
2013-01-17	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+13.5K sh	—	—	414,993
2012-08-07	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+150K sh	—	—	370,017
2012-01-26	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Senior Vice President, Finance	AAward	+125K sh	—	—	220,017
2011-12-06	SYNERGY PHARMACEUTICALS LLCUnitsP Purchase	Senior Vice President, Finance	PPurchase	+1,476 sh	$8.00	+$11.8K	1,476

Recent filings

Accepted (ET)
Jun 104
Denoyer Bernard0001493152-26-028134
SEC(opens sec.gov)
Jun 274
SYNERGY PHARMACEUTICALS, INC.0001104659-16-129539
SEC(opens sec.gov)
Sep 304
SYNERGY PHARMACEUTICALS, INC.0001104659-15-068329
SEC(opens sec.gov)
Sep 164
SYNERGY PHARMACEUTICALS, INC.0001104659-15-065544
SEC(opens sec.gov)
Jul 284
SYNERGY PHARMACEUTICALS, INC.0001104659-15-053882
SEC(opens sec.gov)
Dec 94
SYNERGY PHARMACEUTICALS, INC.0001104659-14-085540
SEC(opens sec.gov)
Feb 204
ContraVir Pharmaceuticals, Inc.0001104659-14-011939
SEC(opens sec.gov)
Jan 284
ContraVir Pharmaceuticals, Inc.0001104659-14-004560
SEC(opens sec.gov)
Nov 264
ContraVir Pharmaceuticals, Inc.0001104659-13-087209
SEC(opens sec.gov)
Jul 174/A
SYNERGY PHARMACEUTICALS, INC.0001104659-13-054906
SEC(opens sec.gov)
Jul 164
SYNERGY PHARMACEUTICALS, INC.0001104659-13-054710
SEC(opens sec.gov)
Jun 244
SYNERGY PHARMACEUTICALS, INC.0001104659-13-050885
SEC(opens sec.gov)
Jan 224
Denoyer Bernard0001104659-13-003847
SEC(opens sec.gov)
Jan 224/A
Denoyer Bernard0001104659-13-003960
SEC(opens sec.gov)

Companies

Address

14-15 CONDUIT ST

LONDON, W1S 2XJ